✦ LIBER ✦

Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: Analysis of prospective randomised phase III trials

✍ Scribed by S. Mahner; C. Eulenburg; A. Staehle; K. Wegscheider; A. Reuss; E. Pujade-Lauraine; P. Harter; I. Ray-Coquard; J. Pfisterer; A. du Bois

Book ID: 119233342
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 633 KB
Volume: 49
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2012.07.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive and prognostic markers for th

Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study

✍ Miriam Koopman; Sabine Venderbosch; Harm van Tinteren; Marjolijn J. Ligtenberg; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 501 KB

The time interval from surgery to start

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study

✍ Hofstetter, G.; Concin, N.; Braicu, I.; Chekerov, R.; Sehouli, J.; Cadron, I.; V 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 376 KB

Re: “Cytoreductive surgery and hyperther

Re: “Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase II trial.” — Proposal of a clinical trial of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer, the CHORINE study.

✍ Luca Ansaloni; Pierandrea De Iaco; Luigi Frigerio 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Prognostic factors for complete debulkin

Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)

✍ Pauline Wimberger; Nils Lehmann; Rainer Kimmig; Alexander Burges; Werner Meier; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 238 KB

39 Topotecan versus treosulfan in recurr

39 Topotecan versus treosulfan in recurrent ovarian cancer after initial chemotherapy with platinum and paclitaxel. a prospective randomised phase III study of the AGO ovarian cancer study group

✍ S. Loibl; W. Meier; A. du Bois; W. Kuhn; J. Pfisterer; R. Kimmig; S. Olbricht; B 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Impact of the time interval between surg

Impact of the time interval between surgery and postoperative radiation therapy on locoregional control in advanced head and neck cancer

✍ Peter B. Schiff; Dr. Louis B. Harrison; Elliot W. Strong; Daniel E. Fass; Jatin 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

## Abstract Between January 1975 and December 1980, 111 patients with AJCC stages III and IV squamous cell carcinoma of the head and neck were treated with surgery followed by planned postoperative radiation therapy. A previous analysis of a subgroup of these patients showed that, when radiation wa